Affiliation:
1. Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicine
2. Kaohsiung Chang Gung Memorial Hospital
3. Chang Gung Memorial Hospital
Abstract
Abstract
Purpose: Tumor necrosis is a significant risk factor affecting patients’ prognosis after liver resection (LR) for hepatocellular carcinoma (HCC). Only one previous study has used a model incorporating tumor necrosis to predict tumor recurrence after LR in patients with a solitary HCC of ≤ 3.0 cm. We aimed to develop a model with tumor necrosis as a variable to predict early tumor recurrence in HCC patients undergoing LR.
Methods: Patients who underwent LR between 2010 and 2018 for newly diagnosed HCC but did not receive neoadjuvant therapy were enrolled in this retrospective study. Six predictive factors based on pathological features—tumor size > 5 cm, multiple tumors, high-grade tumor differentiation, tumor necrosis, microvascular invasion, and cirrhosis—were chosen a priori based on clinical relevance to construct a multivariate logistic regression model. The variables were always retained in the model. The impact of each variable on early tumor recurrence within one year of LR was estimated and visualized using a nomogram. The nomogram’s performance was evaluated using calibration plots with bootstrapping.
Results: Early tumor recurrence was observed in 161 (21.3 %) patients. The concordance index of the proposed nomogram was 0.722. The calibration plots showed good agreement between nomogram predictions and actual observations of early recurrence.
Conclusion: We developed a nomogram incorporating tumor necrosis to predict early recurrence of HCC after LR. Its predictive accuracy is satisfactory.
Publisher
Research Square Platform LLC
Reference42 articles.
1. Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015: A Systematic Analysis for the Global Burden of Disease Study;Fitzmaurice C;JAMA Oncol,2017
2. A global view of hepatocellular carcinoma: Trends, risk, prevention and management;Yang JD;Nat Rev Gastroenterol Hepatol,2019
3. NCCN clinical practice guidelines in oncology: hepatobiliary cancers;Benson AB;J Natl Compr Canc Netw,2009
4. EASL-EORTC clinical practice guidelines. management of hepatocellular carcinoma;European Association for the Study of the Liver, European Organisation For Research and Treatment of Cancer;J Hepatol,2012
5. Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma;Omata M;Hepatol Int,2010